Dr. Reddy’s announces commercial launch of 2-DG
The Hindu
MRP of each sachet ₹990, to be offered at subsidised rate to govt institutions
Drugmaker Dr. Reddy’s Laboratories has announced the commercial launch of 2-deoxy-D-glucose (2-DG), an oral drug for use as an adjunct therapy for hospitalised COVID-19 patients. The maximum retail price is ₹990 per sachet. It will be made available at a subsidised rate to government institutions, the company said, adding its 2-DG has a purity of 99.5%. Dr. Reddy’s said it will be supplying the product to major government as well as private hospitals across the country. In the initial weeks, the product will be made available in hospitals across Metros and Tier-I cities and thereafter taken to the rest of India, a statement from the company said.More Related News